Runben Biotechnology Co., Ltd. (SHA:603193)
China flag China · Delayed Price · Currency is CNY
22.49
+0.12 (0.54%)
Mar 10, 2026, 11:21 AM CST

Runben Biotechnology Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Cash & Equivalents
109.39106.59243.83368.21206.1939.53
Upgrade
Short-Term Investments
-77.951,340---
Upgrade
Trading Asset Securities
1,0211,249198.2456.2442.17
Upgrade
Cash & Short-Term Investments
1,1311,4341,603376.45262.4381.7
Upgrade
Cash Growth
185.34%-10.57%325.85%43.45%221.20%130.74%
Upgrade
Accounts Receivable
32.2413.594.821.192.342.78
Upgrade
Other Receivables
5.424.622.3269.85.73
Upgrade
Receivables
37.6618.227.147.212.158.51
Upgrade
Inventory
135118.5792.91102.7156.945.22
Upgrade
Other Current Assets
316.6124.4313.1623.6812.896.38
Upgrade
Total Current Assets
1,6201,5951,716510.04344.36141.82
Upgrade
Property, Plant & Equipment
292.79267.57260.42277.56207.67108.73
Upgrade
Other Intangible Assets
87.8554.5418.7619.3619.8820.54
Upgrade
Long-Term Deferred Tax Assets
46.244.2320.8214.85.662.39
Upgrade
Long-Term Deferred Charges
1.561.261.41---
Upgrade
Other Long-Term Assets
258.04256.91.133.6568.772.99
Upgrade
Total Assets
2,3072,2192,019825.42646.34276.47
Upgrade
Accounts Payable
84.853.840.1536.9946.3713.27
Upgrade
Accrued Expenses
9.732.1626.2124.4311.415.98
Upgrade
Current Portion of Leases
1.41.371.952.512.4-
Upgrade
Current Income Taxes Payable
25.5126.2915.4718.285.290.63
Upgrade
Current Unearned Revenue
2.9613.375.974.54.23.44
Upgrade
Other Current Liabilities
5.1410.215.369.895.840.92
Upgrade
Total Current Liabilities
129.51137.1995.1296.675.5224.23
Upgrade
Long-Term Leases
0.361.422.045.397.91-
Upgrade
Long-Term Unearned Revenue
3.960.010.010.271.132.05
Upgrade
Long-Term Deferred Tax Liabilities
0.230.270.440.570.140.05
Upgrade
Total Liabilities
134.06138.8897.61102.8384.6926.33
Upgrade
Common Stock
404.59404.59404.59343.9343.9103.07
Upgrade
Additional Paid-In Capital
1,0151,0151,015102.59101.69117.28
Upgrade
Retained Earnings
752.75660.67502.12276.09116.0529.79
Upgrade
Shareholders' Equity
2,1732,0801,921722.59561.65250.14
Upgrade
Total Liabilities & Equity
2,3072,2192,019825.42646.34276.47
Upgrade
Total Debt
1.762.7847.9110.31-
Upgrade
Net Cash (Debt)
1,1291,4311,599368.54252.1281.7
Upgrade
Net Cash Growth
187.16%-10.52%333.90%46.18%208.59%130.74%
Upgrade
Net Cash Per Share
2.813.534.531.080.750.27
Upgrade
Filing Date Shares Outstanding
404.59404.59404.59404.59343.9305.52
Upgrade
Total Common Shares Outstanding
404.59404.59404.59343.9343.9305.52
Upgrade
Working Capital
1,4911,4581,621413.44268.84117.59
Upgrade
Book Value Per Share
5.375.144.752.101.630.82
Upgrade
Tangible Book Value
2,0852,0261,903703.22541.76229.6
Upgrade
Tangible Book Value Per Share
5.155.014.702.041.580.75
Upgrade
Buildings
-231.94232.54231.65163.4743.21
Upgrade
Machinery
-96.787.7779.0657.2229.25
Upgrade
Construction In Progress
-18.071.825.767.1759.01
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.